The American Society of Gene & Cell Therapy (ASGCT) is the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy.

The 28th Annual Meeting will be hosted in New Orleans, May 13-17, 2025

Our Scientific Director, James Goss, will be onsite representing the STXBP1-related disorders community.

And, in conjunction with this major industry event, our partner, Capsida, has announced progress updates, FDA clearance, and toxicology data findings of their CAP-002 STXBP1-DEE gene therapy.